Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Kidney Transplantation
100%
BK Polyomavirus (BKPyV)
100%
International Guidelines
100%
Second International
100%
DNAemia
63%
BK Virus Nephropathy
45%
Biopsy-proven
27%
Graft Dysfunction
18%
Allograft Biopsy
18%
Clinical Trials
9%
Experimental Therapeutics
9%
Clinical Quality
9%
Immunohistochemistry
9%
Clinical Outcomes
9%
Risk Factors
9%
Allograft
9%
Immunosuppression
9%
Acute Rejection
9%
Tacrolimus
9%
Kidney Transplant Recipients
9%
Cytological Diagnosis
9%
Proposed Strategy
9%
Quality of Life
9%
Neutralizing Antibodies
9%
Urine Cytology
9%
Old Age
9%
Male Sex
9%
Kidney Allograft Biopsy
9%
Cidofovir
9%
Calcineurin Inhibitors
9%
Quinolones
9%
Adoptive T Cell
9%
Donor Nephrectomy
9%
Early Intervention
9%
Antiproliferative Drugs
9%
Routine Screening
9%
Grading of Recommendations
9%
Kidney Retransplantation
9%
Assessment Development
9%
Evaluation Assessment
9%
Global Experts
9%
Resource-limited Settings
9%
Viruria
9%
Leflunomide
9%
Immunological Risk
9%
Antiviral Vaccines
9%
Decoy Cells
9%
Medicine and Dentistry
Kidney Transplantation
100%
BK Virus
100%
Biopsy Technique
37%
Nephropathy
31%
Allograft
18%
Renal Graft Dysfunction
12%
Clinical Trial
6%
Health Care Cost
6%
Immunohistochemistry
6%
T Cell
6%
Tacrolimus
6%
Kidney Graft
6%
Acute Graft Rejection
6%
Immunosuppressive Treatment
6%
Quinolone Derivative
6%
Calcineurin Inhibitor
6%
Quality of Life
6%
Graft Dysfunction
6%
Urine Cytology
6%
Nephrectomy
6%
Experimental Therapy
6%
Cidofovir
6%
Early Intervention
6%
Neutralizing Antibody
6%
Antiproliferative Drug
6%
Virus Vaccine
6%
Leflunomide
6%